Exchange: NASDAQ·Updated 11:56 AM EDT
SANA logo

SANA Sana Biotechnology Inc

$3.93
$0.035
(0.90%)
Today
Reported EarningsAug 10
Mkt Cap$1.16B
Vol468,209.00

About SANA

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
49

Neutral Sentiment

How do you feel about SANA?

Advertisement|Remove ads.